Pharmaceutical

Global stock market crash likely to delay biotech IPOs

Biotech IPOs were up six-fold in Q1 2024 from the previous quarter, but the current global stock market crash means a sustained rebound is in jeopardy.

Aug 7, 2024 - 04:00
Global stock market crash likely to delay biotech IPOs
Biotech IPOs were up six-fold in Q1 2024 from the previous quarter, but the current global stock market crash means a sustained rebound is in jeopardy.
Read the original article

Tags:

Previous Article

Developing high-potent APIs: The necessary steps to follow

Next Article

How SaaS platforms are breaking the mold for clinical trials

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Novo Nordisk pauses ads for weight loss drug Wegovy as it struggles to meet demand

STAT+: Novo Nordisk pauses ads for weight loss drug Weg...

May 19, 2023

J&J seeks label expansion for Tremfya in ulcerative colitis

J&J seeks label expansion for Tremfya in ulcerative col...

Mar 13, 2024

STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access

STAT+: Pharmalittle: U.S. to impose inflation penalties...

Dec 15, 2023